Novo Nordisk is Denmark’s big little problem

As war rages and Donald Trump looms, a recent election featured little mention of the ailing $164 bln drugmaker, once so successful it distorted economic figures. In this week’s Viewsroom, Breakingviews columnists discuss the future of weight loss pills, and Novo’s place in it.

This episode has been corrected to remove a statement that Novo Nordisk’s Wegovy pill needs to be refrigerated.

👉 Subscribe: https://reut.rs/4b8fRGn

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on X: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en

Видео Novo Nordisk is Denmark’s big little problem канала Reuters